Abacavir And Lamivudine 31722-0838

Product NDC

31722-0838

Manufacturer: Camber Pharmaceuticals, Inc.
Dosage Form: Tablet, Film Coated
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: April 16, 2025
Listing Expires: December 31, 2026
Application: ANDA205412

Need to source Abacavir And Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Abacavir Sulfate	600 mg/1
Lamivudine	300 mg/1

Drug Class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 1A1 Inhibitors [MoA]

Packaging Options(1)

31722-0838-30

1 BOTTLE in 1 CARTON (31722-838-30) / 30 TABLET, FILM COATED in 1 BOTTLE

View →